Hester Biosciences Financial Statements

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2020 Mar-2018 Mar-2017 Mar-2016
Growth matrix (%)        
Revenue growth 34.80 10.40 22 12.10
Op profit growth 18.20 15.20 22.80 32.70
EBIT growth 22 16.60 20.70 42.60
Net profit growth 13.90 8.81 22.70 41.20
Profitability ratios (%)        
OPM 30.50 34.80 33.30 33.10
EBIT margin 26.70 29.50 28 28.30
Net profit margin 15.90 18.80 19.10 19
RoCE 17.30 18.90 18.40 17.70
RoNW 4.27 4.88 5.26 5.14
RoA 2.58 3.01 3.14 2.98
Per share ratios ()        
EPS 36.40 27.10 26.80 21.70
Dividend per share 6.60 10 5.30 4.10
Cash EPS 18.70 18.80 19.40 15.80
Book value per share 236 165 143 120
Valuation ratios        
P/E 25.40 59.10 28.50 23
P/CEPS 49.40 85.50 39.20 31.60
P/B 3.91 9.70 5.32 4.18
EV/EBIDTA 14.30 28.50 17 14
Payout (%)        
Dividend payout -- 33.20 10.80 21.90
Tax payout (25) (36) (26) (23)
Liquidity ratios        
Debtor days 90.30 79 78.20 79.60
Inventory days 103 98.20 99.40 113
Creditor days (43) (39) (35) (32)
Leverage ratios        
Interest coverage (6.40) (9.90) (9.80) (7.70)
Net debt / equity 0.51 0.39 0.45 0.53
Net debt / op. profit 1.84 1.17 1.33 1.61
Cost breakup ()        
Material costs (11) (17) (23) (19)
Employee costs (22) (17) (15) (15)
Other costs (37) (31) (29) (32)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2020 Mar-2018 Mar-2017 Mar-2016
Revenue 183 136 123 101
yoy growth (%) 34.80 10.40 22 12.10
Raw materials (20) (23) (28) (20)
As % of sales 10.80 17.10 23.10 19.40
Employee costs (41) (23) (18) (15)
As % of sales 22.20 17.10 14.90 15.30
Other costs (67) (42) (35) (33)
As % of sales 36.60 31 28.70 32.20
Operating profit 55.90 47.30 41 33.40
OPM 30.50 34.80 33.30 33.10
Depreciation (13) (9.70) (7) (5.80)
Interest expense (7.70) (4) (3.50) (3.70)
Other income 6.37 2.55 0.42 0.88
Profit before tax 41.30 36.10 30.90 24.80
Taxes (10) (13) (8.10) (5.60)
Tax rate (25) (36) (26) (23)
Minorities and other (1.80) 2.55 0.76 0.01
Adj. profit 29.20 25.60 23.50 19.20
Exceptional items -- -- -- --
Net profit 29.20 25.60 23.50 19.20
yoy growth (%) 13.90 8.81 22.70 41.20
NPM 15.90 18.80 19.10 19
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2018 Mar-2017 Mar-2016
Profit before tax 41.30 36.10 30.90 24.80
Depreciation (13) (9.70) (7) (5.80)
Tax paid (10) (13) (8.10) (5.60)
Working capital 92.50 43.10 33.90 17.40
Other operating items -- -- -- --
Operating cashflow 110 56.50 49.70 30.90
Capital expenditure 168 108 87.60 21.60
Free cash flow 278 164 137 52.40
Equity raised 209 172 151 144
Investments -- -- (0.30) (0.20)
Debt financing/disposal 105 52.50 33.80 20
Dividends paid -- 8.51 2.55 3.49
Other items -- -- -- --
Net in cash 592 397 324 220
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2020 Mar-2019 Mar-2018 Mar-2017
Equity capital 8.51 8.51 8.51 8.51
Preference capital -- -- -- --
Reserves 193 169 132 113
Net worth 201 177 141 122
Minority interest
Debt 126 89.90 68.80 66.20
Deferred tax liabilities (net) 8.82 10.70 10.10 8.81
Total liabilities 342 282 224 202
Fixed assets 216 152 142 124
Intangible assets
Investments -- -- -- --
Deferred tax asset (net) -- -- 2.28 5.26
Net working capital 102 89 66.30 61.10
Inventories 64 50.80 39.80 33.40
Inventory Days 127 -- 107 99.10
Sundry debtors 58.40 32.90 32.30 26.50
Debtor days 116 -- 86.70 78.70
Other current assets 22.10 23.10 16.70 17.70
Sundry creditors (20) (10) (9.90) (9.20)
Creditor days 39.40 -- 26.60 27.20
Other current liabilities (23) (7.60) (13) (7.40)
Cash 23.50 41.10 13.40 11.50
Total assets 342 282 224 202
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Jun-2020 Mar-2020 Dec-2019 Sep-2019 Jun-2019
Gross Sales 39.90 43.60 50.70 44.20 44.80
Excise Duty -- -- -- -- --
Net Sales 39.90 43.60 50.70 44.20 44.80
Other Operating Income -- -- -- -- --
Other Income 0.69 4.79 0.30 0.70 0.58
Total Income 40.60 48.40 51 44.90 45.30
Total Expenditure ** 28 36.40 30 33.10 27.20
PBIDT 12.60 12 21 11.80 18.20
Interest 1.54 2.54 2.63 1.41 1.90
PBDT 11.10 9.44 18.40 10.30 16.30
Depreciation 3.18 3.20 3.42 3.23 3.23
Minority Interest Before NP -- -- -- -- --
Tax 2.95 2.03 3.07 2.15 4.92
Deferred Tax (0.10) (0.60) (0.10) (1.20) 0.02
Reported Profit After Tax 5.05 4.76 12 6.21 8.09
Minority Interest After NP (0.70) 2.02 0.43 (0.30) (0.30)
Net Profit after Minority Interest 5.72 2.74 11.50 6.52 8.39
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 5.72 2.74 11.50 6.52 8.39
EPS (Unit Curr.) 5.94 5.60 14.10 7.30 9.51
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- -- -- -- --
Equity 8.51 8.51 8.51 8.51 8.51
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 31.60 27.50 41.40 26.60 40.50
PBDTM(%) 27.80 21.60 36.20 23.40 36.30
PATM(%) 12.70 10.90 23.60 14 18.10